KR20190037014A - Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component - Google Patents

Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component Download PDF

Info

Publication number
KR20190037014A
KR20190037014A KR1020170126593A KR20170126593A KR20190037014A KR 20190037014 A KR20190037014 A KR 20190037014A KR 1020170126593 A KR1020170126593 A KR 1020170126593A KR 20170126593 A KR20170126593 A KR 20170126593A KR 20190037014 A KR20190037014 A KR 20190037014A
Authority
KR
South Korea
Prior art keywords
extract
aged
fermented product
sprout
buds
Prior art date
Application number
KR1020170126593A
Other languages
Korean (ko)
Other versions
KR102151003B1 (en
Inventor
박상원
조계만
이미라
Original Assignee
경상대학교산학협력단
농업회사법인 드림팜 유한회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경상대학교산학협력단, 농업회사법인 드림팜 유한회사 filed Critical 경상대학교산학협력단
Priority to KR1020170126593A priority Critical patent/KR102151003B1/en
Publication of KR20190037014A publication Critical patent/KR20190037014A/en
Application granted granted Critical
Publication of KR102151003B1 publication Critical patent/KR102151003B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/121Brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/169Plantarum
    • A23Y2220/13
    • A23Y2220/67
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a method for producing a fermented product of aged sprout ginseng extract in which a hangover curing effect is enhanced; a fermented product of aged sprout ginseng extract produced by the method; and a pharmaceutical composition and functional health food for curing hangover, containing a fermented product of aged sprout ginseng extract as an active ingredient. The present invention comprises a step of aging sprout ginseng, a step of extracting the aged sprout ginseng by adding water, a step of sterilizing the extract, and a step of fermenting the sterilized extract.

Description

숙성새싹삼 추출물의 발효물을 유효성분으로 포함하는 숙취해소용 조성물{Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component}TECHNICAL FIELD The present invention relates to a composition for fermented hangover comprising fermented product of aged sprout trifoliate extract as an active ingredient,

본 발명은 숙성새싹삼 추출물의 발효물을 유효성분으로 포함하는 숙취해소용 조성물에 관한 것이다.The present invention relates to a composition for hangover decoy comprising a fermented product of aged sprout trifoliate as an active ingredient.

숙취는 술을 많이 마신 후 나타나는 두통, 속쓰림, 두근거림, 갈증, 멀미, 위장질환, 설사 등의 현상을 말한다. 술의 주성분인 알코올(alcohol)은 신체적, 정신적으로 인체에 미치는 영향이 매우 다양하고 광범위하여 그 대사 과정과 독성 발현 특성에 대한 많은 연구가 진행되고 있다. 섭취된 알코올은 소화관을 통해 흡수되어 섭취 후 20~120분 사이에 최고 혈중 농도에 도달한다. 흡수된 알코올은 간을 비롯한 여러 장기에서 대사될 수 있으며, 약 10%는 호흡이나 소변, 땀으로 배설된다. 알코올을 섭취할 경우 위장 또는 소장에서 흡수되어 혈관 속에 들어가게 되고, 간으로 들어온 알코올은 간세포 세포질 내의 알코올 탈수소효소(alcohol dehydrogenase; ADH)에 의해 알코올이 아세트알데히드(acetaldehyde)로 산화되고, 아세트알데히드는 알데히드 탈수소효소(aldehyde dehydrogenase; ALDH)에 의해 아세테이트(acetate)로 전환되며, 이는 순환계를 통해 간세포 밖으로 배설되어 진다. Hangover is a phenomenon of headache, heartburn, throbbing, thirst, motion sickness, gastrointestinal illness, and diarrhea that appear after drinking a lot of alcohol. Alcohol (alcohol), which is the main ingredient of alcohol, has various effects on the human body both physically and mentally. Therefore, much research has been carried out on the metabolism and toxicity expression characteristics of alcohol. Alcohol ingested is absorbed through the digestive tract and reaches its peak plasma concentration between 20 and 120 minutes after ingestion. Absorbed alcohol can be metabolized in many organs, including the liver, and about 10% is excreted by breathing, urine, or sweat. When alcohol is ingested, it is absorbed in the stomach or small intestine and enters the blood vessels. Alcohol entering the liver is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) in hepatocyte cytoplasm, acetaldehyde is oxidized to acetaldehyde, It is converted to acetate by aldehyde dehydrogenase (ALDH), which is excreted through the circulation system outside the hepatocyte.

특히 알코올의 최초 대사산물인 아세트알데히드는 알코올에 비해 반응성이 매우 높고 독성이 강하여 알코올성 간 장애의 주원인 물질로 알려져 있으며, 세포 내 에너지 생성기관인 미토콘드리아의 호흡을 방해하고 산화적 인산화(oxidative phosphorylation) 반응을 억제하기도 한다. 또한, 아세트알데히드와 아세테이트는 지질과산화반응(lipid peroxidation) 등을 통해 세포독성, 두통이나 복통, 삼투압 변화에 따른 탈수현상 등을 일으키는 것으로 알려져 있다. 과다한 알코올 섭취는 위장질환을 유발할 수 있는데, 심할 경우 위염 또는 위궤양을 일으킬 수 있다. 특히 사회적 스트레스에 의한 빈번한 알코올 섭취는 심각한 위궤양과 함께 간질환을 동반하는 경우가 많다. In particular, acetaldehyde, which is the first metabolite of alcohol, is highly reactive and toxic, and is known to be the main cause of alcoholic liver disorder. It inhibits the respiration of mitochondria in the intracellular energy producing organs and causes oxidative phosphorylation . In addition, acetaldehyde and acetate are known to cause cytotoxicity through lipid peroxidation, dehydration due to headache, abdominal pain, and osmotic pressure change. Excessive alcohol intake can cause gastrointestinal illness, which can lead to gastritis or gastric ulcers. Especially frequent alcohol consumption due to social stress is accompanied with severe gastric ulcer and liver disease.

알데히드 탈수소효소는 아세트알데히드가 저농도이더라도 산화를 개시하는 Ⅱ형과, 아세트알데히드가 고농도로 되지 않으면 작용하지 않는 Ⅰ형이 있으나, 동양인은 일반적으로 Ⅱ형 알데히드 탈수소효소가 결핍 또는 부족하기 때문에 아세트알데히드의 산화가 느리거나, 산화되지 않아 간세포와 체내에 축적된 아세트알데히드 및 에탄올의 유독 작용에 의해 정상적인 신진대사가 방해받아 숙취 현상을 느끼게 되는 것이다. 따라서, 혈중 알코올 농도를 감소시키고 알코올 및 아세트알데히드 분해 촉진을 통한 숙취 해소 방법들이 개발되어 왔으며, 그 중에서도 천연물을 이용하는 방법들이 주목을 받고 있다. The aldehyde dehydrogenase has type Ⅱ which initiates oxidation even when acetaldehyde is low, and type Ⅰ which does not work if acetaldehyde is not used at high concentration. However, since Asian people generally lack or lack Ⅱ type aldehyde dehydrogenase, acetaldehyde Oxidation is slow or not oxidized, and the toxic action of acetaldehyde and ethanol accumulated in the hepatocytes and the body interferes with normal metabolism, and a hangover phenomenon is felt. Therefore, there have been developed methods for reducing hangover by reducing blood alcohol concentration and accelerating decomposition of alcohol and acetaldehyde, among which methods using natural products are attracting attention.

새싹삼은 보통 1~2년의 기간 동안 재배된 인삼으로, 뿌리보다 잎과 줄기에 사포닌 성분이 약 7~8배 더 함유되어 있으며 수경재배, 연중생산 가능 및 재배기간의 단축으로 인해 종래에 이용되는 뿌리인삼보다 낮은 가격을 형성하고 있다는 장점이 있어, 인삼가공품의 원료로서 사용이 용이하다.Sprouts are ginseng cultivated for a period of 1-2 years. The ginseng is about 7-8 times more saponin in the leaves and stems than roots. It is used in hydroponic cultivation, production throughout the year, and shortening of cultivation period. It has a merit that it forms a lower price than root ginseng, and it is easy to use as a raw material of ginseng processed product.

본 발명에서는 유산균에 의해 발효된 숙성새싹삼 추출물이 혈중 알코올 및 아세트알데히드 농도를 감소시키는 효과를 확인하였으며, 이를 유효성분으로 함유하는 숙취 해소용 조성물을 개발하였다. In the present invention, the aged sprout ternate fermented by lactic acid bacteria has been shown to reduce blood alcohol and acetaldehyde concentrations, and a composition for removing hangover containing the active ingredient has been developed.

한편, 한국등록특허 제1766736호에는 '새싹인삼 잎차의 제조방법 및 이로부터 제조된 새싹인삼 잎차'가 개시되어 있고, 한국공개특허 제2016-0067439호에는 '새싹삼의 재배방법 및 새싹삼 재배용 세트'가 개시되어 있으나 본 발명의 숙성새싹삼 추출물의 발효물을 유효성분으로 포함하는 숙취해소용 조성물에 대해서는 기재된 바가 없다. Korean Patent No. 1766736 discloses a process for producing a ginseng leaf tea and a ginseng leaf tea produced therefrom. Korean Patent Laid-Open Publication No. 2016-0067439 discloses a method for cultivating a sprout, However, there is no description about a composition for hangover decoy comprising the fermented product of the aged sprout triple extract of the present invention as an active ingredient.

본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 락토바실러스 플란타룸(Lactobacillus plantarum)과 락토바실러스 브레비스(L. brevis)가 혼합된 유산균 혼합물에 의한 발효과정을 통해 제조된 숙성새싹삼 추출물의 발효물이 새싹삼 추출물 및 숙성인삼 추출물의 발효물에 비해, 실험동물에서 알코올에 의한 정향반사 소실을 억제하고 혈중 알코올 및 아세트알데히드 농도를 감소시키는 것을 확인함으로써, 본 발명을 완성하였다. SUMMARY OF THE INVENTION The present invention has been made in view of the above needs, and it is an object of the present invention to provide a lactic acid bacterium which is obtained by fermenting a mixture of Lactobacillus plantarum and Lactobacillus brevis ( L. brevis ) The inventors of the present invention have completed the present invention by confirming that the fermented product of the extract inhibits the disappearance of the cloaked reflection due to alcohol in the laboratory animal and reduces the concentration of alcohol and acetaldehyde in the blood in comparison with the fermented product of the sprout trifoliate extract and the aged ginseng extract.

상기 과제를 해결하기 위해, 본 발명은 (1) 새싹삼을 증자한 후 숙성시키는 단계; (2) 상기 (1) 단계의 숙성된 새싹삼을 건조시키고, 건조된 숙성새싹삼에 물을 혼합하여 추출하는 단계; (3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 당을 혼합한 후 살균하는 단계; 및 (4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 유산균 혼합물을 접종한 후 발효시키는 단계를 포함하는 것을 특징으로 하는 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법을 제공한다.In order to solve the above-mentioned problems, the present invention provides a method for producing a sprout; (2) drying the aged buds of step (1), mixing and extracting the dried aged buds with water; (3) mixing the prepared aged sprout trum extract prepared in step (2) with sugar and sterilizing it; And (4) a step of inoculating a sterilized aged sprout trum extract of step (3) into a mixture of lactic acid bacteria and fermenting the fermented product. do.

또한, 본 발명은 상기 방법으로 제조된 숙취해소 효과가 증진된 숙성새싹삼 추출물의 발효물을 제공한다.In addition, the present invention provides a fermented product of aged sprout trifoliate extract prepared by the above method, wherein the hangover resolution effect is enhanced.

또한, 본 발명은 상기 방법으로 제조된 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for hangover marrow containing the fermented product of the aged sprout ternary extract prepared by the above method as an active ingredient.

또한, 본 발명은 상기 방법으로 제조된 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 약학 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for hangover medicine comprising a fermented product of the aged sprout ternary extract prepared by the above method as an active ingredient.

본 발명의 숙성새싹삼 추출물의 발효물을 유효성분으로 포함하는 조성물은 천연 약재인 새싹삼을 유효성분으로 사용하므로 인체에 부작용이 없으며, 혈중 알코올 및 아세트알데히드 농도를 효과적으로 감소시킬 수 있으므로, 본 발명의 조성물은 음주 전 후의 숙취해소용 건강기능식품 및 의약품에 유용하게 사용될 수 있을 것으로 기대된다. Since the composition comprising the fermented product of the aged sprout trifoliant extract of the present invention as an effective ingredient has no adverse effect on the human body and effectively reduces the concentration of alcohol and acetaldehyde in the blood, Is expected to be useful for health functional foods and medicines for hangover and abuse before and after drinking.

도 1은 새싹삼 추출물과 숙성새싹삼 추출물의 발효물 및 인삼 추출물과 숙성인삼 추출물의 발효물에 의한 정향반사(righting reflex) 소실 억제 효과를 나타낸 결과이다. water; 물(대조군), SG; 새싹삼 추출물, FSG; 숙성새싹삼 추출물의 발효물, G; 인삼 추출물, FG; 숙성인삼 추출물의 발효물.
도 2는 새싹삼 추출물 및 숙성새싹삼 추출물 발효물에 의한 혈중 알코올(A) 및 아세트알데히드(B) 농도의 감소 효과를 나타낸 결과이다. water; 물(대조군), SG; 새싹삼 추출물, FSG; 숙성새싹삼 추출물의 발효물.
FIG. 1 shows the results of inhibiting the disappearance of righting reflex by fermentation products of ginseng extract, aged sprout, and fermented product of ginseng extract and aged ginseng extract. water; Water (control), SG; Bud extract, FSG; Fermented product of aged sprout triphosphate, G; Ginseng extract, FG; Fermented product of aged ginseng extract.
FIG. 2 shows the results of the reduction of blood alcohol (A) and acetaldehyde (B) concentrations by the fermented product of bud extract and aged sprout trifoliate extract. water; Water (control), SG; Bud extract, FSG; Fermentation products of aged sprout stems.

본 발명의 목적을 달성하기 위하여, 본 발명은 In order to achieve the object of the present invention,

(1) 새싹삼을 증자한 후 숙성시키는 단계;(1) a step of growing and aging the buds;

(2) 상기 (1) 단계의 숙성된 새싹삼을 건조시키고, 건조된 숙성새싹삼에 물을 혼합하여 추출하는 단계;(2) drying the aged buds of step (1), mixing and extracting the dried aged buds with water;

(3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 당을 혼합한 후 살균하는 단계; 및(3) mixing the prepared aged sprout trum extract prepared in step (2) with sugar and sterilizing it; And

(4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 유산균 혼합물을 접종한 후 발효시키는 단계를 포함하는 것을 특징으로 하는 숙취해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법을 제공한다.(4) a step of inoculating a sterilized aged sprout trifoliate extract of step (3) into a fermented product of a fermented product of aged sprout ternary extract enhanced in hangover resolution .

본 발명의 일 구현 예에 따른 숙성새싹삼 추출물의 발효물 제조방법에 있어서, 상기 (3)단계의 당은 유산균이 당을 분해하여 영양분을 형성함으로써 발효를 더욱 원활하게 이루도록 하기 위하여 첨가된다. 본 발명에 사용할 수 있는 당류로는 식품으로 사용할 수 있는 것으로 설탕, 포도당, 과당, 엿류, 당시럽류, 덱스트린, 올리고당류 중에서 하나를 사용하거나 이들을 혼합하여 사용할 수 있고, 바람직하게는 설탕일 수 있으나, 이에 제한되지 않는다.In the method for preparing a fermented product of aged sprout trifoliate extract according to an embodiment of the present invention, the saccharide in step (3) is added in order to make fermentation more smoothly by lactic acid bacteria decomposing sugar to form nutrients. The saccharides usable in the present invention include sugars, glucose, fructose, sugar, sugar syrup, dextrin and oligosaccharides, which may be used as food or may be used in combination. Preferably, But is not limited thereto.

본 발명의 일 구현 예에 따른 숙성새싹삼 추출물의 발효물 제조방법에 있어서, 상기 (4)단계의 유산균 혼합물은 락토바실러스 플란타룸(Lactobacillus plantarum) 균주 및 락토바실러스 브레비스(Lactobacillus brevis) 균주가 혼합된 것일 수 있으며, 더욱 바람직하게는, 각각 1×108~1×1010 CFU/ml의 농도로 준비된 기탁번호 KACC 91848P인 락토바실러스 플란타늄(Lactobacillus plantarum) P1201 균주 및 기탁번호 KACC 92156P인 락토바실러스 브레비스(Lactobacillus brevis) BMK184 균주가 1:1의 비율로 혼합된 것일 수 있으나, 이에 제한되지 않는다. In the method for producing a fermented product of aged sprout trifoliate extract according to an embodiment of the present invention, the lactic acid bacteria mixture in step (4) may be prepared by mixing Lactobacillus plantarum strain and Lactobacillus brevis strain , More preferably Lactobacillus plantarum P1201, which is a deposit number KACC 91848P prepared at a concentration of 1 × 10 8 to 1 × 10 10 CFU / ml, respectively, and Lactobacillus strain KACC 92156P But is not limited to, a mixture of Lactobacillus brevis BMK184 at a ratio of 1: 1.

본 발명의 일 구현 예에 따른 방법에 있어서, 상기 숙성새싹삼 추출물의 발효물의 제조방법은 구체적으로는,In the method according to an embodiment of the present invention, the method for producing the fermented product of the aged sprout stamens extract may be,

(1) 새싹삼을 3~5cm 두께로 세절하고, 세절된 새싹삼을 95~120℃에서 10~60분 동안 증자한 후 70~80℃에서 5~10일간 숙성시키는 단계;(1) sprouting buds 3 to 5 cm in thickness, aging the buds at 95 to 120 ° C for 10 to 60 minutes and aging at 70 to 80 ° C for 5 to 10 days;

(2) 상기 (1) 단계의 숙성된 새싹삼을 50~55℃에서 2~3일간 건조시키고, 건조된 숙성새싹삼에 물을 중량 대비 18~22배 가하여 95~120℃에서 3~6시간 동안 추출하여 숙성새싹삼 추출물을 제조하는 단계;(2) The aged buds of step (1) are dried at 50 to 55 ° C for 2 to 3 days, water is added to the dried aged buds at a rate of 18 to 22 times by weight, To prepare a ripened sprout trifoliate extract;

(3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 당을 추출물 중량 대비 1.5~2.5% (w/v)로 혼합한 후 100~130℃에서 10~30분 동안 살균하는 단계; 및(3) mixing the aged sprout stem extract prepared in step (2) with sugar at a concentration of 1.5 to 2.5% (w / v) based on the weight of the extract, and sterilizing the mixture at 100 to 130 ° C for 10 to 30 minutes; And

(4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 유산균 혼합물을 추출물 중량 대비 4~6% (v/v)로 접종한 후, 25~35℃에서 2~5일 동안 발효시키는 단계를 포함할 수 있으며, 더욱 구체적으로는, (4) a step of inoculating the sterilized aged sprout stem extract of step (3) with the mixture of lactic acid bacteria in an amount of 4 to 6% (v / v) based on the weight of the extract and fermenting the mixture at 25 to 35 ° C for 2 to 5 days And more specifically,

(1) 25~30일간 재배된 새싹삼을 흐르는 물에 3회 세척하고 3~5cm 두께로 세절하여 95~120℃에서 25~35분 동안 증자한 후 70~80℃에서 5~10일간 숙성시키는 단계;(1) The sprouts cultivated for 25 ~ 30 days are washed three times in flowing water, and cut into 3 ~ 5cm thick, and grown at 95 ~ 120 ℃ for 25 ~ 35 minutes and aged at 70 ~ 80 ℃ for 5 ~ 10 days step;

(2) 상기 (1) 단계의 숙성된 새싹삼을 50~55℃에서 2~3일간 건조시키고, 건조된 숙성새싹삼에 물을 중량 대비 20배 가하여 95~100℃에서 4시간 동안 추출하여 1.5 브릭스(brix)의 숙성새싹삼 추출물을 제조하는 단계;(2) The aged buds of step (1) above were dried at 50 to 55 ° C for 2 to 3 days, and water was added to the dried aged buds at a rate of 20 times by weight and extracted at 95 to 100 ° C for 4 hours to obtain 1.5 Preparing a ripened bud triplicate of brix;

(3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 당을 추출물 중량 대비 2% (w/v)로 혼합한 후 121℃에서 15분 동안 살균하는 단계; 및(3) adding the sugar to the aged sprout trum extract prepared in step (2) at a concentration of 2% (w / v) based on the weight of the extract, and sterilizing the mixture at 121 ° C for 15 minutes; And

(4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 각각 1×109 CFU/ml의 농도로 준비된 기탁번호 KACC 91848P인 락토바실러스 플란타룸(Lactobacillus plantarum) P1201 균주 및 기탁번호 KACC 92156P인 락토바실러스 브레비스(Lactobacillus brevis) BMK184 균주가 1:1의 비율로 혼합된 유산균 혼합물을 추출물 중량 대비 5% (v/v)로 접종한 후, 25~35℃에서 2~5일 동안 발효시키는 단계를 포함할 수 있으나, 이에 제한되지 않는다.(4) The Lactobacillus plantarum strain P1201, which is deposited at a concentration of 1 x 10 9 CFU / ml, respectively, in the sterilized aged sprout ternary extract of step (3), and the deposit number KACC 92156P Lactobacillus brevis BMK184 was inoculated at a ratio of 1: 1 in the ratio of 5% (v / v) to the weight of the extract and fermented at 25 to 35 ° C for 2 to 5 days But are not limited thereto.

또한, 본 발명은 상기 제조방법으로 제조된 숙취해소 효과가 증진된 숙성새싹삼 추출물의 발효물을 제공한다.The present invention also provides a fermented product of aged sprout trifoliate extract prepared by the above-described method, wherein the hangover resolution effect is enhanced.

본 발명의 용어 '숙취'는 술에 몹시 취한 상태에서 알코올을 분해하는 알코올 탈수소효소(alcohol dehydrogenase, ADH) 또는 아세트알데히드를 분해하는 알데히드 탈수소효소(aldehyde dehydrogenase, ALDH)가 부족하여 알코올이나 아세트알데히드가 인체 내에 축적되어 발생하는 현상으로, 대표적인 증상은 메스꺼움, 구토, 복통, 설사, 두통, 갈증 또는 위장장애일 수 있으나, 이에 제한되지 않으며, 과음한 후 나타나는 일반적인 현상을 포괄할 수 있다. The term " hangover " of the present invention means that alcohol or acetaldehyde is insufficient in alcohol dehydrogenase (ADH) or aldehyde dehydrogenase (ALDH), which decomposes acetaldehyde, A typical symptom may be nausea, vomiting, abdominal pain, diarrhea, headache, thirst, or gastrointestinal disorder. However, the present invention is not limited to this and can include general phenomena that occur after overeating.

또한, 본 발명은 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 건강기능식품 조성물을 제공한다.Further, the present invention provides a health functional food composition for hangover marrow containing a fermented product of aged sprout triphasic extract as an active ingredient.

상기 숙취해소용 건강기능식품 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다. 상기 건강기능식품 조성물은 숙취를 예방하거나 해소하기 위해 섭취할 수 있는 것이면 특별히 제한되지 않는다.The health food functional food composition for hangover can be manufactured by any one of powder, granule, ring, tablet, capsule, candy, syrup, foamable beverage and beverage, but is not limited thereto. The health functional food composition is not particularly limited as long as it can be ingested to prevent or eliminate hangover.

본 발명의 숙성새싹삼 추출물의 발효물을 식품첨가물로 사용하는 경우, 상기 숙성새싹삼 추출물의 발효물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 숙성새싹삼 추출물의 발효물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 안전성 면에서 아무런 문제가 없는 범위의 양으로 사용될 수 있다.When the fermented product of the aged sprout triple extract of the present invention is used as a food additive, the fermented product of the aged sprout extract can be used as it is or can be used together with other food or food ingredients, and can be suitably used according to a conventional method have. The active ingredient may be suitably used depending on its intended use (prevention or improvement). Generally, the fermented product of the aged sprout trifoliate extract of the present invention is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight, based on the raw material. However, in the case of long-term intake for the purpose of controlling health, it can be used in an amount that does not cause any safety problems.

상기 식품의 종류에는 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다. 상기 음료는 탄산음료, 기능성이온음료, 쥬스(예를 들어, 사과, 배,포도, 알로에, 감귤, 복숭아, 당근, 토마토쥬스 등), 식혜 등을 포함한다. There is no particular limitation on the kind of the food. Examples of the foods to which the health functional food composition can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen and other noodles, gums, ice cream, soups, Drinks, alcoholic beverages, and vitamin complexes, all of which include health foods in a conventional sense. The beverage includes carbonated beverages, functional ionic beverages, juice (e.g., apple, pear, grape, aloe, citrus, peach, carrot, tomato juice, etc.), sikhye, and the like.

본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. The functional food of the present invention includes components that are ordinarily added in food production, and includes, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, in the case of a drink, a natural carbohydrate or a flavoring agent may be included as an additional ingredient in addition to the active ingredient. The natural carbohydrate may be selected from the group consisting of monosaccharides (e.g., glucose, fructose, etc.), disaccharides (e.g., maltose, sucrose etc.), oligosaccharides, polysaccharides (e.g., dextrin, cyclodextrin, , Xylitol, sorbitol, erythritol, etc.). The flavoring agent may be a natural flavoring agent (e.g., tau Martin, stevia extract, etc.) and a synthetic flavoring agent (e.g., saccharin, aspartame, etc.). In addition to the above-mentioned health functional food composition, it is possible to use various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, A carbonating agent used in beverages, and the like.

또한, 본 발명은 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 약학 조성물을 제공한다.The present invention also provides a pharmaceutical composition for hangover surgery comprising a fermented product of aged sprout trifoliate as an active ingredient.

본 발명의 상기 약학 조성물은, 유산균 혼합물에 의한 발효과정을 통해 혈중 알코올 및 아세트알데히드의 농도 감소 효과가 증가된 숙성새싹삼 추출물의 발효물을 유효성분으로 포함하고 있어, 숙취해소의 효과가 있다.The pharmaceutical composition of the present invention contains a fermented product of aged sprout trifoliate extract whose blood alcohol and acetaldehyde concentrations are reduced by the fermentation process with the mixture of lactic acid bacteria as an active ingredient, and thus has the effect of eliminating a hangover.

본 발명의 상기 발효물을 포함하는 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 또는 희석제를 더 포함할 수 있다. The composition comprising the fermented product of the present invention may further comprise suitable carriers, excipients or diluents conventionally used in the production of pharmaceutical compositions.

본 발명의 약학 조성물의 약학적 투여 형태는 단독으로 또는 타 약학적 활성 화합물과 결합뿐만 아니라 적당한 조합으로 사용될 수 있다.The pharmaceutical dosage forms of the pharmaceutical compositions of the present invention may be used alone or in combination with other pharmaceutically active compounds as well as in suitable combinations.

본 발명에 따른 약학 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제제, 외용제, 좌제 및 주사제의 형태로 제형화하여 사용될 수 있다. 상기 약학 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 포함한 다양한 화합물 혹은 혼합물을 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구 투여를 위한 고형 제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형 제제는 상기 발효물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트, 수크로오스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이 외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔, 마크로골, 트윈 61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.The pharmaceutical composition according to the present invention may be formulated in the form of powders, granules, tablets, capsules, oral preparations such as suspensions, emulsions, syrups and aerosols, external preparations, suppositories and injections according to conventional methods . Examples of carriers, excipients and diluents that can be contained in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, and the like. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose or lactose, gelatin, . In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of liquid formulations for oral use include suspensions, solutions, emulsions and syrups. In addition to water and liquid paraffin, which are commonly used simple diluents, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like have. Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include withexol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.

본 발명의 상기 약학 조성물의 바람직한 투여량은 환자의 상태 및 체중,질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 본 발명의 약학 조성물은 쥐, 생쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁 내 경막 또는 뇌혈관 내(intracerebroventricular) 주사에 의해 투여될 수 있다.The preferred dosage of the pharmaceutical composition of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the type of drug, the administration route and the period of time, but can be appropriately selected by those skilled in the art. The pharmaceutical composition of the present invention can be administered to mammals such as rats, mice, livestock, humans, and the like in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine or intracerebroventricular injections.

이하, 본 발명을 실시예에 의해 상세히 설명한다 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.EXAMPLES Hereinafter, the present invention will be described in detail with reference to Examples. However, the following Examples are illustrative of the present invention, and the present invention is not limited to the following Examples.

제조예 1. 새싹삼 및 인삼 추출물 제조Production Example 1. Preparation of bud extract and ginseng extract

시중에서 구입한 5년근 인삼과 드림팜(유)로부터 공급받은 25일~30일간 재배된 새싹삼을 흐르는 물에 3회 세척하고, 물기를 제거하여 3~5cm 크기로 세절한 후 50~55℃에서 2~3일간 건조시켰다. 상기 건조된 새싹삼과 인삼에 정제수를 중량 대비 60배 가하여 95~100℃에서 12시간 동안 추출하여 새싹삼 및 인삼 추출물을 제조하였다. It is washed three times in running water for 5 to 30 days, which is obtained from 5-year-old root ginseng and dream palm (purchased from the market) purchased from the market. After removing water, it is cut into 3 ~ For 2 to 3 days. Purified water was added to dried ginseng and ginseng 60 times by weight and extracted at 95 to 100 ° C for 12 hours to prepare ginseng extract and ginseng extract.

제조예 2. 숙성새싹삼 및 숙성인삼 추출물의 발효물 제조Preparation Example 2. Fermentation of aged sprout and aged ginseng extract

상기 제조예 1에서 세절된 새싹삼과 인삼을 95~100℃에서 30분 동안 증자하고 70~80℃에서 5~10일간 숙성시킨 다음 50~55℃에서 2~3일간 건조시켰다. 상기 건조된 숙성새싹삼과 숙성인삼에 정제수를 각각 중량 대비 20배 첨가하고 95~100℃에서 4시간 동안 추출하여 발효를 위한 1.5 브릭스(brix)의 숙성새싹삼 또는 숙성인삼 추출물을 제조하였다.The buds and ginseng sliced in Preparation Example 1 were grown at 95-100 ° C for 30 minutes, aged at 70-80 ° C for 5-10 days, and then dried at 50-55 ° C for 2-3 days. The dried agar-agar and aged ginseng were respectively added 20 times by weight of purified water and extracted at 95 to 100 ° C for 4 hours to prepare a 1.5-brix aged sprout or aged ginseng extract for fermentation.

상기 숙성새싹삼과 숙성인삼 추출물에 설탕을 각 추출물의 중량 대비 2%(w/v)로 첨가한 후 121℃에서 15분 동안 살균시키고, 살균된 각각의 추출물에 1×109 CFU/ml의 락토바실러스 플란타룸(Lactobacillus plantarum) P1201 균주(KACC 91848P) 및 1×109 CFU/ml의 락토바실러스 브레비스(L. brevis) BMK184 균주(KACC 92156P)를 추출물 중량 대비 각각 2.5%(v/v)로 접종한 후 30~35℃에서 2~5일 동안 발효시켜 숙성새싹삼 및 숙성인삼 추출물의 발효물을 제조하였다. The sugar was added to the aged ginseng extract and aged ginseng extract in an amount of 2% (w / v) based on the weight of each extract and sterilized at 121 ° C for 15 minutes. To each of the sterilized extracts, 1 × 10 9 CFU / ml of lactose Lactobacillus plantarum strain P1201 (KACC 91848P) and 1 × 10 9 CFU / ml L. brevis BMK184 strain (KACC 92156P) were added to the extract at a concentration of 2.5% (v / v) After inoculation, they were fermented at 30 ~ 35 ℃ for 2 ~ 5 days to prepare fermented product of aged sprout and aged ginseng extract.

실시예 1. 숙성새싹삼 추출물의 발효물의 숙취예방 효과 - 정향반사 소실 억제 효과 분석Example 1. Prevention of hangover in fermented products of aged sprout trifoliate extracts

알코올 섭취에 따른 정향반사 소실에 대하여 본 발명의 숙성새싹삼 추출물의 발효물이 미치는 효과를 분석하였다. 실험에 앞서 8주령의 수컷 ICR 마우스는 사료 섭취로 인해 나타날 수 있는 위장관을 통한 알코올의 흡수 방해 현상을 배재하기 위해 18시간 동안 절식시켰다. 먼저 마우스에 물, 10 ml/kg의 새싹삼 추출물(SG), 2.5 ml/kg과 10 ml/kg의 숙성새싹삼 추출물의 발효물(FSG), 10 ml/kg의 인삼 추출물(G) 및 10 ml/kg의 숙성인삼 추출물(FG)을 각각 경구투여하고, 1시간 후에 30 ml/kg의 18% 에탄올을 복강투여한 후 행동학적 변화를 하기 기준에 따라 점수화하였으며, 각 시간별 행동학적 변화에 해당하는 점수 및 시간 그래프의 곡선하면적(Area under curve, AUC)을 분석하였다(표 1).The effect of the fermented product of the aged sprout trifoliate extract of the present invention on the disappearance of the clinging reflection due to alcohol consumption was analyzed. Prior to the experiment, 8-week-old male ICR mice were fasted for 18 hours to evade the absorption of alcohol through the gastrointestinal tract, which may be due to feed intake. First, the mice were injected with water, 10 ml / kg of sprout trifoliate (SG), 2.5 ml / kg and 10 ml / kg fermented product of aged sprout triple extract (FSG), 10 ml / kg of ginseng extract ml / kg of aged ginseng extract (FG) were administered orally. After 1 hour, 30 ml / kg of 18% ethanol was intraperitoneally administered and the behavioral changes were scored according to the following criteria. The area under curve (AUC) of scores and time graphs was analyzed (Table 1).

정상행동 : 0점Normal behavior: 0 point

뒷다리를 끌며 기어간다 : 1점Crawl with hind legs: 1 point

뒤집어 놓으면 정상 자세를 취하나 앞으로 전진하지 못한다 : 2점If you turn it upside down, you get normal posture but can not move forward: 2 points

뒤집어 놓아도 그대로 있으며 정상자세로 돌아오지 못한다 : 3점Even if you turn it upside down, you can not return to normal posture: 3 points

곡선하면적(area under curve, AUC)The area under curve (AUC) WaterWater 10 ml/kg SG10 ml / kg SG 2.5 ml/kg FSG2.5 ml / kg FSG 10 ml/kg FSG10 ml / kg FSG AUCAUC 100100 96.596.5 90.490.4 70.270.2 WaterWater 10 ml/kg G10 ml / kg of G 10 ml/kg FG10 ml / kg FG
AUCAUC 100100 103103 102102

그 결과, 물을 섭취한 대조군에 비해 새싹삼 추출물 및 숙성새싹삼 추출물의 발효물을 섭취한 군에서 AUC 값이 감소함을 확인하였고, 특히 10 ml/kg의 숙성새싹삼 추출물 발효물을 섭취한 군이 대조군 및 새싹삼 추출물을 섭취한 군에 비해 AUC 값이 현저하게 감소함을 확인하였다. As a result, it was confirmed that the AUC value was decreased in the group fed with the fermented product of the sprout triplet and the aged sprout triple extract, compared with the control group in which the water was consumed. Especially, the fermented product of the fermented product of the aged sprout triple extract of 10 ml / kg AUC values were significantly decreased in the control group and the bud extract group.

또한, 인삼 추출물 및 숙성인삼 추출물의 발효물을 섭취한 군과 물을 섭취한 대조군의 AUC 값이 유사한 것을 확인함으로써, 본 발명의 숙성새싹삼 추출물의 발효물이 숙성인삼 추출물의 발효물에 비해 정향반사 소실을 효과적으로 억제함으로써, 숙취예방에 효과가 있음을 알 수 있었다(도 1). In addition, by confirming that the AUC values of the group ingesting the fermented product of the ginseng extract and the aged ginseng extract and the control group consuming the water were similar, it was confirmed that the fermented product of the aged sprout trifoliate extract of the present invention was more effective than the fermented product of the aged ginseng extract It was found that it was effective in preventing hangover by effectively suppressing loss of reflection (FIG. 1).

실시예 2. 숙성새싹삼 추출물 발효물의 숙취해소 효과 - 혈중 알코올 및 아세트알데히드 농도 저감 효과 분석Example 2. Effect of eliminating the hangover of the fermented product of aged sprout trifoliate extract - Effect of reducing alcohol and acetaldehyde concentration in blood

알코올 섭취에 따른 혈중 알코올 및 아세트알데히드 농도 변화에 대하여 본 발명의 숙성새싹삼 추출물의 발효물이 미치는 효과를 분석하였다. 상기 실시예 1의 절식한 ICR 마우스에 물, 새싹삼 추출물 및 새싹삼 추출물의 발효물을 먼저 투여하고 1시간 후, 10 ml/kg의 18% 에탄올을 투여한 다음 1, 3 및 6시간 후에 대정맥에서 채혈하였고, 채혈된 혈액을 원심분리하여 혈청을 획득하였으며, Ethanol Assay Kit(ab65343) 및 Aldehyde Quantification Assay Kit (Colorimetric)(ab112113)(Abcam, 미국)를 이용하여 혈청에 함유된 에탄올 및 아세트알데히드의 농도를 측정하였다. The effects of the fermented product of the aged sprout trifoliate extract of the present invention on the changes in blood alcohol and acetaldehyde concentrations due to alcohol consumption were analyzed. The fermented product of water, sprout trilobite, and sprout trum extract was first administered to the fasted ICR mouse of Example 1, and 1 hour later, 10 ml / kg of 18% ethanol was administered. After 1, 3, and 6 hours, And serum was obtained by centrifugation of collected blood. Ethanol and acetaldehyde contained in the serum were measured using Ethanol Assay Kit (ab65343) and Aldehyde Quantification Assay Kit (Colorimetric) (ab112113) (Abcam, USA) .

그 결과, 1시간 후부터 새싹삼 추출물 또는 숙성새싹삼 추출물의 발효물을 섭취한 실험군의 혈중 알코올 농도가 물만 섭취한 대조군에 비해 낮은 것을 확인하였으며, 특히 동량의 새싹삼 추출물을 섭취한 실험군에 비해 숙성새싹삼 추출물의 발효물을 섭취한 실험군의 혈중 알코올 농도가 현저하게 낮은 것을 확인하였다(도 2A).As a result, it was confirmed that the blood alcohol concentration in the experimental group consumed the fermented product of the bud extract or the aged bud extract was lower than that of the control group consumed only the water from 1 hour after the fermentation. In particular, It was confirmed that the blood alcohol concentration in the experimental group consumed the fermented product of the sprout trifoliate was remarkably low (FIG. 2A).

또한, 혈중 아세트알데히드 농도는 알코올 섭취 후 3시간 동안 지속적으로 증가하였으나, 물만 섭취한 대조군에 비해 새싹삼 추출물 또는 숙성새싹삼 추출물의 발효물을 섭취한 실험군의 혈중 아세트알데히드 농도가 감소된 것을 확인할 수 있었으며, 특히 동량의 새싹삼 추출물 발효물을 섭취한 실험군은 숙성새싹삼 추출물을 섭취한 실험군에 비해 혈중 아세트알데히드 농도가 더 많이 감소된 것을 확인하였다(도 2B). 이를 통해, 본 발명의 숙성새싹삼 추출물의 발효물은 혈중 알코올 및 아세트알데히드의 농도를 낮춤으로써 숙취해소에 효과가 있음을 유추할 수 있었다.In addition, the blood acetaldehyde concentration was continuously increased for 3 hours after the alcohol intake, but the blood acetaldehyde concentration in the blood of the experimental group consumed the bud extract or the aged sprout extract was lower than that of the control group In particular, it was confirmed that the test group consuming the same amount of the triplet extract fermented with the same amount showed a further decrease in the blood acetaldehyde concentration as compared with the group that ingested the aged bud extract (FIG. 2B). Thus, the fermented product of the aged sprout trifoliate extract of the present invention can be deduced to be effective in reducing hangover by lowering the concentration of alcohol and acetaldehyde in blood.

농업생명공학연구원Agricultural Biotechnology Research Institute KACC91848PKACC91848P 2013071920130719 농업생명공학연구원Agricultural Biotechnology Research Institute KACC92156PKACC92156P 2016121220161212

Claims (9)

(1) 새싹삼을 증자한 후 숙성시키는 단계;
(2) 상기 (1) 단계의 숙성된 새싹삼을 건조시키고, 건조된 숙성새싹삼에 물을 혼합하여 추출하는 단계;
(3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 당을 혼합한 후 살균하는 단계; 및
(4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 유산균 혼합물을 접종한 후 발효시키는 단계;를 포함하는 것을 특징으로 하는 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법.
(1) a step of growing and aging the buds;
(2) drying the aged buds of step (1), mixing and extracting the dried aged buds with water;
(3) mixing the prepared aged sprout trum extract prepared in step (2) with sugar and sterilizing it; And
(4) A method for producing a fermented product of a fermented product of aged sprout trifoliate extract, wherein the fermented product is fermented after the lactic acid bacteria mixture is inoculated into the sterilized aged sprout trum extract of step (3).
제1항에 있어서, 상기 (4)단계의 유산균 혼합물은 락토바실러스 플란타룸(Lactobacillus plantarum) 균주 및 락토바실러스 브레비스(Lactobacillus brevis) 균주가 혼합된 것을 특징으로 하는 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법.The method according to claim 1, wherein the lactic acid bacteria mixture in step (4) is a mixture of Lactobacillus plantarum strain and Lactobacillus brevis strain. A method for producing a fermented product of an extract. 제2항에 있어서, 상기 (4)단계의 유산균 혼합물은 기탁번호 KACC 91848P인 락토바실러스 플란타룸(Lactobacillus plantarum) P1201 균주 및 기탁번호 KACC 92156P인 락토바실러스 브레비스(Lactobacillus brevis) BMK184 균주가 혼합된 것을 특징으로 하는 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법.The lactic acid bacteria mixture according to claim 2, wherein the lactic acid bacteria mixture in step (4) is a mixture of Lactobacillus plantarum P1201 strain with accession number KACC 91848P and Lactobacillus brevis BMK184 strain with accession number KACC 92156P A method for producing a fermented product of aged sprout trifoliate extract having improved hangover resolution effect. 제1항에 있어서,
(1) 새싹삼을 세절하고, 세절된 새싹삼에 95~100℃에서 20~40분 동안 증자한 후 70~80℃에서 5~10일간 숙성시키는 단계;
(2) 상기 (1) 단계의 숙성된 새싹삼을 50~55℃에서 2~3일간 건조시키고, 건조된 숙성새싹삼에 물을 첨가하여 95~100℃에서 3~5시간 동안 추출하여 숙성새싹삼 추출물을 제조하는 단계;
(3) 상기 (2) 단계의 제조된 숙성새싹삼 추출물에 설탕을 추출물 중량 대비 1.5~2.5% (w/v)로 혼합한 후 110~130℃에서 10~20분 동안 살균하는 단계; 및
(4) 상기 (3) 단계의 살균된 숙성새싹삼 추출물에 각각 1×108~1×1010 CFU/ml의 농도로 준비된 기탁번호 KACC 91848P인 락토바실러스 플란타룸(Lactobacillus plantarum) P1201 균주 및 기탁번호 KACC 92156P인 락토바실러스 브레비스(L. brevis) BMK184 균주를 혼합한 유산균 혼합물을 접종한 후, 30~35℃에서 2~5일 동안 발효시키는 단계;를 포함하는 것을 특징으로 하는 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물의 제조방법.
The method according to claim 1,
(1) blooming the buds, growing the buds at 95-100 ° C for 20-40 minutes, and aging them at 70-80 ° C for 5-10 days;
(2) The aged buds of step (1) are dried at 50 to 55 ° C for 2 to 3 days, water is added to the dried aged buds and the mixture is extracted at 95 to 100 ° C for 3 to 5 hours, Preparing a ternary extract;
(3) mixing the aged sprout stem extract prepared in step (2) with sugar at a concentration of 1.5 to 2.5% (w / v) based on the weight of the extract, and sterilizing the mixture at 110 to 130 ° C for 10 to 20 minutes; And
(4) Lactobacillus plantarum strain P1201, which is deposited at a concentration of 1 × 10 8 to 1 × 10 10 CFU / ml, respectively, in the sterilized aged sprout triplet of step (3), and KACC 91848P A step of inoculating a lactic acid bacteria mixture in which Lactobacillus brevis Lactobacillus strain KACC 92156P Lactobacillus brevis BMK184 is mixed and fermenting at 30 to 35 ° C for 2 to 5 days. A method for producing a fermented product of an aged sprout triple extract.
제1항 내지 제4항 중 어느 한 항의 제조방법으로 제조된 숙취 해소 효과가 증진된 숙성새싹삼 추출물의 발효물.A fermented product of aged sprout trifoliate extract prepared by the method of any one of claims 1 to 4, wherein the hangover resolution effect is enhanced. 제5항의 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 건강기능식품 조성물.A health functional food composition for hangover marine supplements containing a fermented product of the aged sprout trifoliant extract of claim 5 as an active ingredient. 제6항에 있어서, 상기 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조되는 것을 특징으로 하는 숙취해소용 건강기능식품 조성물.The health functional food composition according to claim 6, wherein the composition is prepared from any one of powder, granule, ring, tablet, capsule, candy, syrup, foamable beverage and beverage. 제5항의 숙성새싹삼 추출물의 발효물을 유효성분으로 함유하는 숙취해소용 약학 조성물.A pharmaceutical composition for hangover decomposition comprising the fermented product of the aged sprout trifoliant of claim 5 as an active ingredient. 제8항에 있어서, 상기 숙성새싹삼 추출물의 발효물은 혈중 알코올 및 아세트알데히드의 농도를 감소시키는 것을 특징으로 하는 숙취해소용 약학 조성물.9. The pharmaceutical composition according to claim 8, wherein the fermented product of the aged sprout stamen extract reduces the concentration of alcohol in the blood and acetaldehyde.
KR1020170126593A 2017-09-28 2017-09-28 Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component KR102151003B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170126593A KR102151003B1 (en) 2017-09-28 2017-09-28 Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170126593A KR102151003B1 (en) 2017-09-28 2017-09-28 Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component

Publications (2)

Publication Number Publication Date
KR20190037014A true KR20190037014A (en) 2019-04-05
KR102151003B1 KR102151003B1 (en) 2020-09-02

Family

ID=66103971

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170126593A KR102151003B1 (en) 2017-09-28 2017-09-28 Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component

Country Status (1)

Country Link
KR (1) KR102151003B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210037153A (en) 2019-09-27 2021-04-06 대봉엘에스 주식회사 Cosmetic composition comprising the sprout fermentation and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170085990A (en) * 2016-01-15 2017-07-25 김유근 Method of increase the bioactive effectiveness of sprout ginseng
KR101766736B1 (en) * 2016-02-25 2017-08-09 충남대학교산학협력단 Manufacturing method for leaf tea using Panax ginseng sprout and leaf tea using Panax ginseng sprout manufactured therefrom

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170085990A (en) * 2016-01-15 2017-07-25 김유근 Method of increase the bioactive effectiveness of sprout ginseng
KR101766736B1 (en) * 2016-02-25 2017-08-09 충남대학교산학협력단 Manufacturing method for leaf tea using Panax ginseng sprout and leaf tea using Panax ginseng sprout manufactured therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
숙취해소에 정말 좋은 삼 엑기스(online 2014. 8. 25.) 인터넷: <URL: https://blog.naver.com/insamleaf/220102831724>* *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210037153A (en) 2019-09-27 2021-04-06 대봉엘에스 주식회사 Cosmetic composition comprising the sprout fermentation and preparation method thereof

Also Published As

Publication number Publication date
KR102151003B1 (en) 2020-09-02

Similar Documents

Publication Publication Date Title
KR101135576B1 (en) Compositions for prevention and improvement of cancer containing the extracts of native plants as an active ingredient
KR101782848B1 (en) Composition for eliminating hangover and preventing, improving or treating alcoholic gastrointestinal diseases comprising Dolichos lablab extract as effective component
KR102130332B1 (en) Health fuctional food composition for preventing or improving liver diseases comprising Gastrodia elata and larva
CN114128813A (en) Beverage for relieving alcoholism and protecting liver and promoting vitality of liver and preparation method thereof
KR20140067826A (en) Composition comprising sargassum fulvellum extract for preventing or treating inflammatory diseases
KR101467698B1 (en) Anti-microbial composition comprising cynanchi wilfordii radix extract and the use thereof
JP2009046446A (en) Immunostimulator
KR20180042936A (en) a composition comprising the mycelium culture medium from Schizophyllum commune as an active ingredient for preventing or treating liver disease and alleviating hangover
KR20190037014A (en) Composition for eliminating hangover comprising fermented liquor of aged sprout ginseng extract as effective component
KR100977076B1 (en) Anti-helicobacter composition containing schizandra sp extract and rubus careabus extract
KR20190046245A (en) Composition for preventing, improving or treating liver disease comprising fermented liquor of aged sprout ginseng extract as effective component
KR102133473B1 (en) A composition as a prebiotic for improving intestinal microflora containing sweet potato vines
KR101962893B1 (en) Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract
KR101970320B1 (en) Composition for preventing, improving or treating respiratory diseases comprising fermented solution of Chaenomeles sinensis as effective component and production method thereof
KR101074348B1 (en) Anti-helicobacter composition containing green algae extract
KR101750854B1 (en) A antibiotic composition for Helicobacter pylori containing the propolis extraction fractions thereof or subfractional extrats isolated therefrom
KR102302047B1 (en) Composition for hepatoprotective and ameliorating hangover
KR102416208B1 (en) Anti-influenza viral composition comprising fermentated extract of inula britannica flower
KR20180128781A (en) A method for manufacturing kolaviron
KR20180006612A (en) Compositions for preventing or treating diabetes mellitus comprising extract of Aster koraiensis or fraction thereof
KR101074347B1 (en) Anti-helicobacter composition containing green algae extract
KR100996617B1 (en) Anti-helicobacter composition containing green algae extract
KR101904819B1 (en) Composition comprising Fermented Momordica charantia L. and Allium sativum L. using Amyloliquefaciens Bacillus Jis-1 for lowering blood glucose or preventing and treating diabetes mellitus
KR20170036254A (en) Method for producing fermented Lentinula edodes for improving liver function
KR20230144935A (en) Functional food composition comprising chicory extracts, aged pumpkin fermentation and psyllium husk powder

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant